Case-control study of interactions between genetic and environmental factors in Parkinson's disease

Lancet

Volumn 352, Issue 9145, 1998, Pages 1986-1987

  De Palma, Giuseppe ^b   Mozzoni, Paola ^b   Mutti, Antonio ^a,b   Calzetti, Stefano ^b   Negrotti, Anna ^b  

^a N and H S   (Italy)

^b UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE DELETION; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

EID: 0011933530     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61332-3     Document Type: Article

References (5)

1. 1 Rostami-Hodjegan A, Lennard MS, Woods HF, Tucker GT, Metaanalysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease. Pharmacogenetics 1998; 8: 227-38.
2. 2 Arand M, Muhlbauer R, Hengstler J, et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTMI and GSTTI polymorphisms. Anal Biochem 1996; 236: 184-86.
3. 3 Hastings TG, Zigmond MJ. LOSS of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites. J Neural Transm Suppl 1997; 49; 103-10.
4. 4 Uitti RJ, Snow BJ, Shinotoh H, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994; 35: 616-19.
5. 5 Mutti A, Franchini I. Toxicity of metabolites to dopaminergic systems and the behavioural effects of organic solvents. Br J Ind Med 1987; 44: 721-23.